Navigation Links
IMMULITE 2000 IGFBP-3

ProductsIMMULITE 2000 IGFBP-3
Company Siemens Medical Solutions Diagnostics
Item IMMULITE 2000 IGFBP-3
Features 
Description IMMULITE 2000 assays are designed for use with the IMMULITE 2000, a high-throughput, continuous random access immunoassay analyzer. IMMULITE 2000 offers testing efficiency through centralization, and a rapidly expanding menu for effective patient management.
Info Siemens Medical Solutions Diagnostics
Customer Service: 800-255-3232 or 914-631-8000
Web site: http://www.siemens.com/diagnostics-products

Related medicine products :

1. IMMULITE Phenytoin
2. IMMULITE 2000 Troponin I
3. IMMULITE 2500 STAT Troponin I
4. IMMULITE 2000 Cortisol
5. IMMULITE/IMMULITE 1000 Cortisol
6. IMMULITE 2500 Cortisol
7. IMMULITE/IMMULITE 1000 IGF-I
8. IMMULITE 2500 IGF-I
9. IMMULITE 2000 IGF-I
10. IMMULITE/IMMULITE 1000 Growth Hormone (hGH)
11. IMMULITE 2000 Growth Hormone (hGH)
Breaking Medicine Technology:Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11Octapharma Aims to Expand U S Immune Globulin Therapy Portfolio 14224 1Octapharma Aims to Expand U S Immune Globulin Therapy Portfolio 14224 2Octapharma Aims to Expand U S Immune Globulin Therapy Portfolio 14224 3Oxygen Biotherapeutics Inc Receives Phase II Trial Approval in Israel 5033 1Oxygen Biotherapeutics Inc Receives Phase II Trial Approval in Israel 5033 2Discovery could improve hepatitis C treatment 58129 1Discovery could improve hepatitis C treatment 58129 2